Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT07622797 · RECRUITING
Trial details
- NCT number
- NCT07622797
- Sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-21
- Primary completion
- 2028-12-31
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.